According to Okura et al., high Cdc42 expression is associated with poorer progression-free survival, and Cdc42 expression is highest in the proneural and neural subgroups of GBM [16]; similarly, the expression of bcl-2 had a significant relationship with survival as well [19]. The gene discussed is CDC42; the disease is glioblastoma.